» Articles » PMID: 4514304

A Polypeptide Region of Bovine Prothrombin Specific for Binding to Phospholipids

Overview
Specialty Science
Date 1973 May 1
PMID 4514304
Citations 20
Authors
Affiliations
Soon will be listed here.
Abstract

The blood-clotting protein prothrombin can be converted to thrombin in free solution by the proteolytic enzyme, activated factor X. When prothrombin is bound to the surface of phospholipid vesicles, the rate of thrombin generation is increased more than 30-fold over the rate of unbound prothrombin. If the prothrombin activation process is terminated after a time interval in which less than 10% of the expected thrombin has been produced, two major products are found in the activation mixture. These products have been termed intermediate 1, a precursor of thrombin, and fragment 1. The conversion of intermediate 1 to thrombin is not accelerated by phospholipid nor can binding of this intermediate to phospholipid particles be demonstrated. In contrast, fragment 1, the other activation product derived from prothrombin, binds to phospholipid particles under the same conditions as prothrombin. On the basis of these observations, we propose that the prothrombin molecule contains a specific region of polypeptide chain for binding to phospholipid particles. This specific polypeptide region or lipid interaction site is part of the nonthrombin-forming activation fragment.

Citing Articles

Structure and function of factor X: properties, activation, and activity in prothrombinase. A retrospective in a historical context.

Jackson C J Thromb Thrombolysis. 2021; 52(2):371-378.

PMID: 33725285 DOI: 10.1007/s11239-021-02421-7.


Membrane binding by prothrombin mediates its constrained presentation to prothrombinase for cleavage.

Bradford H, Orcutt S, Krishnaswamy S J Biol Chem. 2013; 288(39):27789-800.

PMID: 23940050 PMC: 3784695. DOI: 10.1074/jbc.M113.502005.


Procoagulant activity, but not number, of microparticles increases with age and in individuals after a single venous thromboembolism.

Owen B, Xue A, Heit J, Owen W Thromb Res. 2010; 127(1):39-46.

PMID: 21106230 PMC: 3076027. DOI: 10.1016/j.thromres.2010.10.018.


Fate of membrane-bound reactants and products during the activation of human prothrombin by prothrombinase.

Kamath P, Krishnaswamy S J Biol Chem. 2008; 283(44):30164-73.

PMID: 18765660 PMC: 2573076. DOI: 10.1074/jbc.M806158200.


Inhibition of thrombin activity by prothrombin activation fragment 1.2.

Dasgupta S, Thiagarajan P J Thromb Thrombolysis. 2007; 24(2):157-62.

PMID: 17334934 DOI: 10.1007/s11239-007-0018-8.


References
1.
Stenn K, BLOUT E . Mechanism of bovine prothrombin activation by an insoluble preparation of bovine factor X a (thrombokinase). Biochemistry. 1972; 11(24):4502-15. DOI: 10.1021/bi00774a012. View

2.
Hemker H, Muller A, Loeliger E . Two types of prothrombin in vitamin K deficiency. Thromb Diath Haemorrh. 1970; 23(3):633-7. View

3.
Laemmli U . Cleavage of structural proteins during the assembly of the head of bacteriophage T4. Nature. 1970; 227(5259):680-5. DOI: 10.1038/227680a0. View

4.
Troll W, CANNAN R . A modified photometric ninhydrin method for the analysis of amino and imino acids. J Biol Chem. 1953; 200(2):803-11. View

5.
LOCHANG T, Sweeley C . CHARACTERIZATION OF LIPIDS FROM CANINE ADRENAL GLANDS. Biochemistry. 1963; 2:592-604. DOI: 10.1021/bi00903a036. View